Health Habitat
Healthy Habits, Happy Life!






CURRENT PERSPECTIVE

Separating Fact from Fiction: Generative AI in Pharma
Generative AI is a type of artificial intelligence capable of creating new content, including text, videos, images, and audio. By learning patterns and structures from existing data, it can generate novel content that is similar but not identical.
This technology presents a significant opportunity for pharmaceutical companies to address their unique challenges. It is estimated that generative AI could contribute between $60 billion and $110 billion annually to the economic value of the pharmaceutical industry. This potential impact spans various areas, including commercial operations, research and development (R&D), drug discovery, and clinical development.
Given the recent surge of interest in generative AI, it’s essential to differentiate between its actual capabilities within the pharmaceutical industry and the hype surrounding it.
Top Stories
Interesting Read

The Global Threat of Antimicrobial Resistance: A Critical Public Health Challenge
Antimicrobial resistance (AMR) claims millions of lives, driven by the misuse of antibiotics. Drug-resistant infections undermine treatment efforts, with low-income countries bearing the greatest burden. Immediate global action is essential.